Rating History for GlaxoSmithKline (GSK) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for GSK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/25/2025 Graham Perry Upgrade Neutral
(Underperform)		 N/A
(N/A)		 47.19
(54.51)		 15.51% Details